NCT01665651

Brief Summary

Patients with serious chronic renal insufficiency usually develop secondary osteoporosis or bone loss, especially those with chronic dialysis, and the degree of bone loss is corrected with decrease of renal function. In traditional Chinese medicine, kidney function is considered to dominate bone development and metabolism. Kidney Yin and Yang replenishment will help improve bone development and metabolism.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2012

Longer than P75 for phase_2

Geographic Reach
1 country

3 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 15, 2012

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

May 8, 2017

Status Verified

May 1, 2017

Enrollment Period

4.8 years

First QC Date

August 8, 2012

Last Update Submit

May 4, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone Mineral Density

    3 months

Secondary Outcomes (4)

  • Kidney Yin and Yang evaluation

    3 months

  • bone metabolism

    3 months

  • Blood Urea Nitrogen

    3 months

  • creatinine

    3 months

Other Outcomes (2)

  • miRNA array

    3 months

  • bone morphogenetic protein 7

    3 months

Study Arms (4)

kidney Yin deficiency with placebo

PLACEBO COMPARATOR

chronic renal insufficiency patients with kidney Yin deficiency evaluated with traditional Chinese medicine will be given Zuogui granules placebo treatment besides basic treatment.

Drug: Zuogui granules placebo

kidney Yang deficiency with placebo

PLACEBO COMPARATOR

chronic renal insufficiency patients with kidney Yang deficiency evaluated with traditional Chinese medicine will be given Yougui granules placebo treatment besides basic treatment.

Drug: Yougui granules placebo

kidney Yin deficiency with Zuogui

EXPERIMENTAL

chronic renal insufficiency patients with kidney Yin deficiency evaluated with traditional Chinese medicine will be given Zuogui granules treatment besides basic treatment.

Drug: Zuogui granules

kidney Yang deficiency with Yougui

EXPERIMENTAL

chronic renal insufficiency patients with kidney Yang deficiency evaluated with traditional Chinese medicine will be given Yougui granules treatment besides basic treatment.

Drug: Yougui granules

Interventions

Yougui granules is traditional Chinese patent medicine used to treatment patients with kidney Yang deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

kidney Yang deficiency with Yougui

Zuogui granules is traditional Chinese patent medicine used to treatment patients with kidney Yin deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

kidney Yin deficiency with Zuogui

Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

kidney Yang deficiency with placebo

Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.

kidney Yin deficiency with placebo

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • chronic renal insufficiency
  • bone loss or osteoporosis
  • years old
  • kidney Yin or Yang deficiency evaluated with traditional Chinese medicine
  • be willing to and be able to join in the study and signed Informed consent
  • have not accepted systematical treatment on bone loss or osteoporosis

You may not qualify if:

  • allergies
  • secondary osteoporosis caused by other diseases.
  • postmenopausal women
  • mental illness or psychosis
  • patients with bone fracture and need surgery treatment
  • taking any medicine that will affect bone metabolism for a long time and can not stop
  • women during pregnant stage and breast-feed stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

The first affiliated hospital of Anhui University of TCM

Hefei, Anhui, 230031, China

Location

Huadong hospital affiliated to Fudan University

Shanghai, Shanghai Municipality, 200000, China

Location

Longhua Hospital affiliated to Shanghai Uni of TCM

Shanghai, Shanghai Municipality, 200032, China

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicChronic Kidney Disease-Mineral and Bone Disorder

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRicketsBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesCalcium Metabolism DisordersVitamin D DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersHyperparathyroidism, SecondaryHyperparathyroidismParathyroid DiseasesEndocrine System Diseases

Study Officials

  • Yongjun Wang, Doctor

    Longhua hospital affiliated to Shanghai Uni of TCM

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant research fellow

Study Record Dates

First Submitted

August 8, 2012

First Posted

August 15, 2012

Study Start

August 1, 2012

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

May 8, 2017

Record last verified: 2017-05

Locations